Cargando…
Long-Term Persistence with Injectable Therapy in Relapsing-Remitting Multiple Sclerosis: An 18-Year Observational Cohort Study
Disease modifying therapies (DMTs) reduce the frequency of relapses and accumulation of disability in multiple sclerosis (MS). Long-term persistence with treatment is important to optimize treatment benefit. This long-term, cohort study was conducted at the Calgary MS Clinic. All consenting adults w...
Autores principales: | Zhornitsky, Simon, Greenfield, Jamie, Koch, Marcus W., Patten, Scott B., Harris, Colleen, Wall, Winona, Alikhani, Katayoun, Burton, Jodie, Busche, Kevin, Costello, Fiona, Davenport, Jeptha W., Jarvis, Scott E., Lavarato, Dina, Parpal, Helene, Patry, David G., Yeung, Michael, Metz, Luanne M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4395027/ https://www.ncbi.nlm.nih.gov/pubmed/25867095 http://dx.doi.org/10.1371/journal.pone.0123824 |
Ejemplares similares
-
1,25-Dihydroxyvitamin D(3) Protects against Immune-Mediated Killing of Neurons in Culture and in Experimental Autoimmune Encephalomyelitis
por: Sloka, Scott, et al.
Publicado: (2015) -
Discriminative ability of quality of life measures in multiple sclerosis
por: Fiest, Kirsten M., et al.
Publicado: (2017) -
Prolactin in combination with interferon-β reduces disease severity in an animal model of multiple sclerosis
por: Zhornitsky, Simon, et al.
Publicado: (2015) -
Advanced diffusion MRI and image texture analysis detect widespread brain structural differences between relapsing-remitting and secondary progressive multiple sclerosis
por: Oladosu, Olayinka, et al.
Publicado: (2022) -
MRI texture heterogeneity in the optic nerve predicts visual recovery after acute optic neuritis()
por: Zhang, Yunyan, et al.
Publicado: (2014)